Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Common Equity (2019 - 2025)

Cresco Labs filings provide 7 years of Common Equity readings, the most recent being $340.4 million for Q4 2025.

  • On a quarterly basis, Common Equity fell 28.3% to $340.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $340.4 million, a 28.3% decrease, with the full-year FY2025 number at $340.4 million, down 28.3% from a year prior.
  • Common Equity hit $340.4 million in Q4 2025 for Cresco Labs, down from $474.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $755.6 million in Q4 2021 to a low of $340.4 million in Q4 2025.
  • Median Common Equity over the past 5 years was $474.9 million (2024), compared with a mean of $517.3 million.
  • Biggest five-year swings in Common Equity: soared 59.66% in 2021 and later fell 28.3% in 2025.
  • Cresco Labs' Common Equity stood at $755.6 million in 2021, then fell by 22.22% to $587.7 million in 2022, then dropped by 27.16% to $428.1 million in 2023, then rose by 10.93% to $474.9 million in 2024, then dropped by 28.3% to $340.4 million in 2025.
  • The last three reported values for Common Equity were $340.4 million (Q4 2025), $474.9 million (Q4 2024), and $428.1 million (Q4 2023) per Business Quant data.